Variant report
Variant | esv3407275 |
---|---|
Chromosome Location | chr6:149498209-149500207 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:37)
- CpG islands (count:0)
- Chromatin interactive region (count:2)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
(count:37 , 50 per page) page:
1
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | ARID3A | chr6:149497988-149498629 | HepG2 | liver: | n/a | n/a |
2 | BHLHE40 | chr6:149498199-149498559 | HepG2 | liver: | n/a | n/a |
3 | CEBPB | chr6:149498187-149498474 | HepG2 | liver: | n/a | n/a |
4 | CEBPB | chr6:149498194-149498437 | HepG2 | liver: | n/a | n/a |
5 | CTCF | chr6:149499280-149499430 | NB4 | blood: | n/a | n/a |
6 | EP300 | chr6:149498015-149498557 | HepG2 | liver: | n/a | n/a |
7 | EP300 | chr6:149498123-149498628 | HepG2 | liver: | n/a | n/a |
8 | FOXA1 | chr6:149498059-149498696 | HepG2 | liver: | n/a | n/a |
9 | FOXA1 | chr6:149497954-149498716 | HepG2 | liver: | n/a | n/a |
10 | FOXA1 | chr6:149498075-149498722 | HepG2 | liver: | n/a | n/a |
11 | FOXA1 | chr6:149497938-149498772 | HepG2 | liver: | n/a | n/a |
12 | FOXA2 | chr6:149497498-149498960 | HepG2 | liver: | n/a | n/a |
13 | FOXA2 | chr6:149498040-149498623 | HepG2 | liver: | n/a | n/a |
14 | HDAC2 | chr6:149498027-149498601 | HepG2 | liver: | n/a | chr6:149498368-149498382 chr6:149498366-149498380 chr6:149498364-149498378 |
15 | HDAC2 | chr6:149498093-149498535 | HepG2 | liver: | n/a | chr6:149498368-149498382 chr6:149498366-149498380 chr6:149498364-149498378 |
16 | HNF4G | chr6:149498194-149498498 | HepG2 | liver: | n/a | chr6:149498348-149498364 |
17 | JUND | chr6:149498267-149498570 | HepG2 | liver: | n/a | n/a |
18 | MBD4 | chr6:149498018-149498589 | HepG2 | liver: | n/a | n/a |
19 | MBD4 | chr6:149498058-149498624 | HepG2 | liver: | n/a | n/a |
20 | MYBL2 | chr6:149497920-149498744 | HepG2 | liver: | n/a | n/a |
21 | MYBL2 | chr6:149497970-149498615 | HepG2 | liver: | n/a | n/a |
22 | NFIC | chr6:149498082-149498518 | HepG2 | liver: | n/a | n/a |
23 | NFIC | chr6:149497965-149498684 | HepG2 | liver: | n/a | n/a |
24 | NR2F2 | chr6:149498020-149498520 | HepG2 | liver: | n/a | n/a |
25 | NR2F2 | chr6:149497988-149498712 | HepG2 | liver: | n/a | n/a |
26 | RAD21 | chr6:149498254-149498579 | HepG2 | liver: | n/a | n/a |
27 | RCOR1 | chr6:149498196-149498488 | HepG2 | liver: | n/a | n/a |
28 | REST | chr6:149498083-149498550 | HepG2 | liver: | n/a | chr6:149498286-149498306 chr6:149498286-149498306 |
29 | RFX5 | chr6:149498188-149498472 | HepG2 | liver: | n/a | n/a |
30 | RXRA | chr6:149498117-149498570 | HepG2 | liver: | n/a | n/a |
31 | SMC3 | chr6:149498267-149498477 | HepG2 | liver: | n/a | n/a |
32 | SP1 | chr6:149498093-149498530 | HepG2 | liver: | n/a | n/a |
33 | SPI1 | chr6:149500131-149500477 | HL-60 | blood: | n/a | n/a |
34 | TCF12 | chr6:149498145-149498502 | HepG2 | liver: | n/a | n/a |
35 | TCF7L2 | chr6:149498107-149498568 | HepG2 | liver: | n/a | n/a |
36 | TEAD4 | chr6:149497942-149498614 | HepG2 | liver: | n/a | n/a |
37 | ZBTB33 | chr6:149498017-149498563 | HepG2 | liver: | n/a | n/a |
No data |
(count:2 , 50 per page) page:
1
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000263481 | TF binding region |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs9498241 | chr6:149498250-149498251 | Enhancers Flanking Active TSS Weak transcription Bivalent Enhancer | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
2 | rs7751665 | chr6:149498383-149498384 | Enhancers Flanking Active TSS Weak transcription Bivalent Enhancer | TF binding region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
3 | rs77021503 | chr6:149498449-149498450 | Enhancers Flanking Active TSS Weak transcription Bivalent Enhancer | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
4 | rs563304469 | chr6:149498455-149498456 | Enhancers Flanking Active TSS Weak transcription Bivalent Enhancer | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
5 | rs191084436 | chr6:149498492-149498493 | Enhancers Flanking Active TSS Weak transcription Bivalent Enhancer | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
6 | rs552247699 | chr6:149498591-149498592 | Enhancers Flanking Active TSS Weak transcription Bivalent Enhancer | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
7 | rs138392010 | chr6:149498609-149498610 | Enhancers Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
8 | rs7776204 | chr6:149498654-149498655 | Enhancers Weak transcription | TF binding region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
9 | rs143888263 | chr6:149498668-149498669 | Enhancers Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
10 | rs548421914 | chr6:149498685-149498686 | Enhancers Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
11 | rs568335853 | chr6:149498694-149498695 | Enhancers Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
12 | rs111412570 | chr6:149498697-149498698 | Enhancers Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
13 | rs537348523 | chr6:149498699-149498700 | Enhancers Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
14 | rs556559294 | chr6:149498700-149498701 | Enhancers Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
15 | rs201601803 | chr6:149498706-149498707 | Enhancers Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
16 | rs538132380 | chr6:149498707-149498708 | Enhancers Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
17 | rs576377967 | chr6:149498758-149498759 | Enhancers Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
18 | rs538682893 | chr6:149498805-149498806 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
19 | rs558992840 | chr6:149498812-149498813 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
20 | rs182138891 | chr6:149498813-149498814 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
21 | rs541197578 | chr6:149498820-149498821 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
22 | rs561147556 | chr6:149498848-149498849 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
23 | rs545850399 | chr6:149498886-149498887 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
24 | rs375115174 | chr6:149498935-149498936 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
25 | rs574750453 | chr6:149499029-149499030 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs111892980 | chr6:149499081-149499082 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs563873245 | chr6:149499099-149499100 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs191343260 | chr6:149499129-149499130 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs551921785 | chr6:149499134-149499135 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs559367472 | chr6:149499179-149499180 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs6920082 | chr6:149499206-149499207 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
32 | rs375138558 | chr6:149499240-149499241 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs184782841 | chr6:149499241-149499242 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs537286675 | chr6:149499296-149499297 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
35 | rs140538295 | chr6:149499298-149499299 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
36 | rs111924647 | chr6:149499308-149499309 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
37 | rs6920401 | chr6:149499312-149499313 | Weak transcription | TF binding region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
38 | rs373397832 | chr6:149499315-149499316 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
39 | rs143607433 | chr6:149499371-149499372 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
40 | rs376555981 | chr6:149499372-149499373 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
41 | rs558700861 | chr6:149499387-149499388 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
42 | rs367941570 | chr6:149499390-149499391 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
43 | rs375097995 | chr6:149499399-149499400 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
44 | rs66954498 | chr6:149499400-149499401 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
45 | rs368167911 | chr6:149499401-149499402 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
46 | rs6920868 | chr6:149499408-149499409 | Weak transcription | TF binding region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
47 | rs187998115 | chr6:149499449-149499450 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs554682923 | chr6:149499452-149499453 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs78019633 | chr6:149499454-149499455 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs73600091 | chr6:149499457-149499458 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
Disease | PMID | Source |
---|---|---|
Uveal melanoma | 21693616 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Biliary cancer | 19435499 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Malaria | 21533027 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Autism | 21448237 | CNVD |
Autism | 22495311 | CNVD |
Biliary cancer | 20360734 | CNVD |
Breast cancer | 20360734 | CNVD |
Coronary artery disease | 20360734 | CNVD |
Crohn''s disease | 20360734 | CNVD |
Hypertension | 20360734 | CNVD |
Rheumatoid arthritis | 20360734 | CNVD |
Type 1 diabetes | 20360734 | CNVD |
Type 2 diabetes | 20360734 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Melanoma | 18172304 | CNVD |
Cancer | 21637783 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Follicular lymphoma | 19010834 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Breast cancer | 16608533 | CNVD |
Non-small cell lung cancer | 21385341 | CNVD |
Prostate cancer | 16705090 | CNVD |
Adenoid cystic carcinoma | 17372589 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Ependymoma | 16718352 | CNVD |
Gastric cancer | 17908304 | CNVD |
High-proliferative meningiomas | 17937814 | CNVD |
Intracranial tumor | 16823260 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Breast cancer | 16272173 | CNVD |
Wilms tumour | 21544195 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Follicular lymphoma | 20505157 | CNVD |
Congenital diaphragmatic hernia | 21085971 | CNVD |
Malignant melanoma | 18718029 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Breast cancer | 21858162 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Breast cancer | 17603634 | CNVD |
Developmental delay | 19490664 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Adenoid cystic carcinoma | 18698036 | CNVD |
head and neck squamous cell carcinoma | 17671120 | CNVD |
Leukemia | 18688285 | CNVD |
Renal cell carcinoma | 18592004 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Malignant melanoma | 17260012 | CNVD |
Prostate cancer | 18632612 | CNVD |
Lung cancer | 18438408 | CNVD |
Soft tissue tumor | 16732325 | CNVD |
Burkitt''s lymphoma | 19759907 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Cancer | 17160897 | CNVD |
Breast cancer | 17417639 | CNVD |
Breast cancer | 17850661 | CNVD |
Renal cell carcinoma | 18765545 | CNVD |
T-cell acute lymphoblastic leukemia | 18185524 | CNVD |
Breast cancer | 17133270 | CNVD |
Breast cancer | 21804112 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Ovarian neoplasms | 16753589 | CNVD |
Retinoblastoma | 22278416 | CNVD |
Breast cancer | 20556506 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr6:149492200-149503600 | Weak transcription | Right Atrium | heart |
2 | chr6:149497800-149498600 | Bivalent Enhancer | HepG2 | liver |
3 | chr6:149498200-149498400 | Enhancers | Rectal Mucosa Donor 29 | rectum |
4 | chr6:149498200-149498600 | Enhancers | Cortex derived primary cultured neurospheres | brain |
5 | chr6:149498200-149498600 | Enhancers | Ganglion Eminence derived primary cultured neurospheres | brain |
6 | chr6:149498200-149498600 | Flanking Active TSS | Liver | Liver |
7 | chr6:149498200-149498600 | Enhancers | Brain Angular Gyrus | brain |
8 | chr6:149498200-149498600 | Enhancers | Brain Hippocampus Middle | brain |
9 | chr6:149498200-149498800 | Enhancers | Foreskin Melanocyte Primary Cells skin03 | Skin |
10 | chr6:149500000-149500600 | Enhancers | Primary monocytes fromperipheralblood | blood |
11 | chr6:149500000-149500600 | Enhancers | Monocytes-CD14+_RO01746 | blood |
12 | chr6:149500000-149500800 | Enhancers | Adipose Nuclei | Adipose |